PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $128,000 | -87.5% | 44,151 | -86.4% | 0.00% | -80.0% |
| Q2 2019 | $1,023,000 | -3.9% | 325,833 | +13.8% | 0.02% | -25.9% |
| Q1 2019 | $1,065,000 | +264.7% | 286,288 | +184.3% | 0.03% | +285.7% |
| Q4 2018 | $292,000 | -21.9% | 100,689 | -10.4% | 0.01% | +16.7% |
| Q1 2016 | $374,000 | -8.1% | 112,375 | -2.3% | 0.01% | +20.0% |
| Q4 2015 | $407,000 | – | 115,021 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |